SIGNR1/CD209b Antibody (143) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-90609
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Format
Concentration
Product Specifications
Immunogen
Clonality
Host
Isotype
Description
Scientific Data Images for SIGNR1/CD209b Antibody (143) - Azide and BSA Free
Immunocytochemistry/Immunofluorescence: SIGNR1/CD209b Antibody (143) [NBP2-90609] -
Immunocytochemistry/Immunofluorescence: SIGNR1/CD209b Antibody (143) [NBP2-90609] - Immunofluorescence staining of mouse SIGNR1/CD209b in mouse splenocytes. Cells were fixed with 4% PFA, blocked with 10% serum, and incubated with NBP2-90609 antibody (1:60) at 37C 1 hour. Then cells were stained with the Alexa Fluor(R) 488-conjugated Goat Anti-rabbit IgG Secondary antibody (green).Flow Cytometry: SIGNR1/CD209b Antibody (143) [NBP2-90609] -
Flow Cytometry: SIGNR1/CD209b Antibody (143) [NBP2-90609] - Flow cytometric analysis of Mouse SIGNR1/CD209b expression on BABL/c splenocytes. Cells were stained with NBP2-90609, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.Applications for SIGNR1/CD209b Antibody (143) - Azide and BSA Free
Immunocytochemistry/ Immunofluorescence
Formulation, Preparation, and Storage
Purification
Formulation
Format
Preservative
Concentration
Shipping
Stability & Storage
Background: SIGNR1/CD209b
Mouse SIGNR1 is a type II transmembrane protein that is a homolog of human DCSIGN (R). It is a C-type lectin expressed by marginal zone macrophages and by medullary and subcapsular macrophages in lymph nodes. SIGN R1 binds and mediates the uptake of dextran via mannose and fucose binding sites.
Long Name
Alternate Names
Gene Symbol
Additional SIGNR1/CD209b Products
Product Documents for SIGNR1/CD209b Antibody (143) - Azide and BSA Free
Product Specific Notices for SIGNR1/CD209b Antibody (143) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.